BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17343821)

  • 1. Implications of naturalistic use of pharmacotherapy in CBT treatment for panic disorder.
    Arch JJ; Craske MG
    Behav Res Ther; 2007 Jul; 45(7):1435-47. PubMed ID: 17343821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Panic disorder].
    Finnish Medical Society Duodecim and The Finnish Academy
    Duodecim; 2000; 116(22):2534-41. PubMed ID: 12053350
    [No Abstract]   [Full Text] [Related]  

  • 3. Naturalistic manner of benzodiazepine use and cognitive behavioral therapy outcome in panic disorder with agoraphobia.
    Westra HA; Stewart SH; Conrad BE
    J Anxiety Disord; 2002; 16(3):233-46. PubMed ID: 12214810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical inquiries. What are effective treatments for panic disorder?
    Sturpe DA; Weissman AM
    J Fam Pract; 2002 Sep; 51(9):743. PubMed ID: 12366889
    [No Abstract]   [Full Text] [Related]  

  • 5. Is a combined therapy more effective than either CBT or SSRI alone? Results of a multicenter trial on panic disorder with or without agoraphobia.
    van Apeldoorn FJ; van Hout WJ; Mersch PP; Huisman M; Slaap BR; Hale WW; Visser S; van Dyck R; den Boer JA
    Acta Psychiatr Scand; 2008 Apr; 117(4):260-70. PubMed ID: 18307586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rate of improvement during and across three treatments for panic disorder with or without agoraphobia: cognitive behavioral therapy, selective serotonin reuptake inhibitor or both combined.
    Van Apeldoorn FJ; Van Hout WJ; Timmerman ME; Mersch PP; den Boer JA
    J Affect Disord; 2013 Sep; 150(2):313-9. PubMed ID: 23676529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of cognitive-behavioral therapy or selective serotonin reuptake inhibitor or both combined for panic disorder with or without agoraphobia: treatment results through 1-year follow-up.
    van Apeldoorn FJ; Timmerman ME; Mersch PP; van Hout WJ; Visser S; van Dyck R; den Boer JA
    J Clin Psychiatry; 2010 May; 71(5):574-86. PubMed ID: 20492852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Panic disorder.
    Kumar S; Oakley-Browne M
    Clin Evid; 2006 Jun; (15):1438-52. PubMed ID: 16973055
    [No Abstract]   [Full Text] [Related]  

  • 9. SECOND-STAGE TREATMENTS FOR RELATIVE NONRESPONDERS TO COGNITIVE BEHAVIORAL THERAPY (CBT) FOR PANIC DISORDER WITH OR WITHOUT AGORAPHOBIA-CONTINUED CBT VERSUS SSRI: A RANDOMIZED CONTROLLED TRIAL.
    Payne LA; White KS; Gallagher MW; Woods SW; Shear MK; Gorman JM; Farchione TJ; Barlow DH
    Depress Anxiety; 2016 May; 33(5):392-9. PubMed ID: 26663632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of panic disorder with agoraphobia in an anxiety disorders clinic: factors influencing psychiatrists' treatment choices.
    Starcevic V; Linden M; Uhlenhuth EH; Kolar D; Latas M
    Psychiatry Res; 2004 Jan; 125(1):41-52. PubMed ID: 14967551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated treatment of panic disorder.
    Rosenbaum JF; Pollock RA; Otto MW; Pollack MH
    Bull Menninger Clin; 1995; 59(2 Suppl A):A4-26. PubMed ID: 7795571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial.
    Simon NM; Otto MW; Worthington JJ; Hoge EA; Thompson EH; Lebeau RT; Moshier SJ; Zalta AK; Pollack MH
    J Clin Psychiatry; 2009 Nov; 70(11):1563-70. PubMed ID: 19814948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WCA recommendations for the long-term treatment of panic disorder.
    Pollack MH; Allgulander C; Bandelow B; Cassano GB; Greist JH; Hollander E; Nutt DJ; Okasha A; Swinson RP;
    CNS Spectr; 2003 Aug; 8(8 Suppl 1):17-30. PubMed ID: 14767395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical issues in the long-term treatment of panic disorder.
    Rosenbaum JF; Pollack MH; Pollock RA
    J Clin Psychiatry; 1996; 57 Suppl 10():44-8; discussion 49-50. PubMed ID: 8917131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic subgroups for remission and response in the Coordinated Anxiety Learning and Management (CALM) trial.
    Kelly JM; Jakubovski E; Bloch MH
    J Clin Psychiatry; 2015 Mar; 76(3):267-78. PubMed ID: 25562579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of CBT, SSRI, and CBT+SSRI in the treatment for panic disorder.
    van Apeldoorn FJ; Stant AD; van Hout WJ; Mersch PP; den Boer JA
    Acta Psychiatr Scand; 2014 Apr; 129(4):286-95. PubMed ID: 23834587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open study of the effectiveness of Internet treatment for panic disorder delivered in a psychiatric setting.
    Bergström J; Andersson G; Karlsson A; Andréewitch S; Rück C; Carlbring P; Lindefors N
    Nord J Psychiatry; 2009; 63(1):44-50. PubMed ID: 18985514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 15-year follow-up study of patients with panic disorder.
    Andersch S; Hetta J
    Eur Psychiatry; 2003 Dec; 18(8):401-8. PubMed ID: 14680716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does concurrent drug intake affect the long-term outcome of group cognitive behaviour therapy in panic disorder with or without agoraphobia?
    Oei TP; Llamas M; Evans L
    Behav Res Ther; 1997 Sep; 35(9):851-7. PubMed ID: 9299805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized effectiveness trial of cognitive-behavioral therapy and medication for primary care panic disorder.
    Roy-Byrne PP; Craske MG; Stein MB; Sullivan G; Bystritsky A; Katon W; Golinelli D; Sherbourne CD
    Arch Gen Psychiatry; 2005 Mar; 62(3):290-8. PubMed ID: 15753242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.